TY - GEN A1 - Gabler, Mariella T1 - Development of an affinity-based method for the site-selective synthesis of antibody-drug-conjugates N2 - For the site-selective synthesis of ADCs, a variety of obstacles must be overcome. Those include designing bifunctional affinity peptides with reasonably low 𝐾𝑑-values that couple to the mAb in a site-selective manner. These peptides should also include a functional group that links the payload to the mAb under mild conditions without adversely affecting it. The bioconjugation between peptide and antibody and the linker between peptide and payload must be stable and durable to provide safety when used for medical purposes. The usage of metals and organic solvents should be minimized. Within the project, new types of functionalized affinity peptides were designed, and their affinity towards the Fc-fragment was determined. KW - Antibody drug conjugate KW - ADC KW - Human antibody KW - Peptide KW - Linker KW - Toxin KW - Payload KW - Monomethyl Auristatin E KW - MMAE KW - DM1 KW - Click chemistry KW - Copper-catalyzed KW - SDS-PAGE KW - HPLC KW - Trastuzumab KW - Herceptin KW - SPR KW - MALDI-TOF-MS KW - Mertansine KW - Site-selective bioconjugation KW - Affinity PY - 2021 SP - 1 EP - 100 PB - Humboldt-Universität zu Berlin CY - Berlin AN - OPUS4-54519 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER -